Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.10M | -6.27M | -7.64M | -7.63M | -7.71M |
| Total Depreciation and Amortization | 494.30K | 508.20K | 512.90K | 511.80K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.63M | -1.68M | 1.11M | 1.11M | 3.88M |
| Change in Net Operating Assets | -- | -- | 2.32M | 2.32M | -- |
| Cash from Operations | -7.24M | -7.44M | -3.69M | -3.68M | -3.84M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 976.70K | 1.00M | -- | -- | -- |
| Cash from Investing | 976.70K | 1.00M | -- | -- | -- |
| Total Debt Issued | -- | -- | 2.20M | 2.20M | 1.48M |
| Total Debt Repaid | -950.00K | -950.00K | -1.10M | -1.10M | -1.48M |
| Issuance of Common Stock | 22.92M | 22.92M | 13.77M | 13.77M | 1.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.67M | -3.67M | -918.10K | -918.10K | -67.20K |
| Cash from Financing | 11.93M | 12.26M | 9.19M | 9.17M | 645.00K |
| Foreign Exchange rate Adjustments | 153.70K | 158.10K | -4.40K | -4.40K | -3.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.82M | 5.98M | 5.50M | 5.49M | -3.20M |
